MedPath

Dual Implant Versus Single Implant Distal End of Femur

Not Applicable
Recruiting
Conditions
Femur Fracture
Interventions
Procedure: Single Distal Femur Implant
Procedure: Dual Distal Femur Implant
Registration Number
NCT06032299
Lead Sponsor
Mayo Clinic
Brief Summary

This research study is being conducted to examine the effect of two versus one fixation device for fixation of distal femur fractures.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Femur fracture distal to the femoral diaphysis.
  • Operative treatment within 72 hours of presenting to the treating hospital.
  • Patient was previously ambulatory.
  • Fracture amendable to either single or dual implant fixation.
  • Informed consent can be obtained from the patient, family member, or power of attorney.
Exclusion Criteria
  • Associated major lower extremity fracture.
  • Ongoing infection.
  • History of metabolic bone disease (Paget's, etc).
  • Pathologic fracture.
  • Open fracture.
  • Severe cognitive impairment (Six Item Screener with 3 or more errors).
  • Stage 5 Parkinson's disease.
  • Significant femoral bone loss requiring planned staged bone grafting.
  • Vascular injury.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Single Distal Femur Implant GroupSingle Distal Femur ImplantSubjects will receive one of two types of implants for the distal femur fracture. The single implant will be either a plate and screws or a rod. The type of single implant used will be determined by the surgeon based on the characteristics of the fracture.
Dual Distal Femur Implant GroupDual Distal Femur ImplantSubjects will receive two implants for fixation of the distal femur fracture. The dual implant will be either 2 plates with screws or a plate with screws and a rod. The type of dual implant used will be determined by the surgeon based on the characteristics of the fracture.
Primary Outcome Measures
NameTimeMethod
Number of study-eligible subjectsBaseline

Total number of subjects to be enrolled in the study

Secondary Outcome Measures
NameTimeMethod
Early post-surgical complications2 weeks post-surgery

Number of subjects to experience venous thromboembolism (VTE), cardiopulmonary, and/or infectious complications after surgery

Hospitalization daysapproximately 2-3 days

Total number of days a subject requires hospitalization after surgery

Blood lossDuration of surgery, approximately 2-4 hours

Total amount of surgical blood loss, reported in mL.

Operative timesDuration of surgery, approximately 2-4 hours

Total recorded amount of time in minutes to complete the surgery

Trial Locations

Locations (1)

Mayo Clinic Minnesota

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath